Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Congress Fiddles While Reimportation Issue Burns
Several drug re-importation bills are currently being considered in Congress

Two Senate bills, the Pharmaceutical Market Access and Drug Safety Act of 2004 (S.2328) and the Safe IMPORT Act of 2004 (S.2493), are likely to meet head-to-head in conference committee. While neither may make it out alive in this session of Congress, the issue of re-importation, however, is not likely to go away.

This article offers a useful comparison of the provisions of these bills and illustrates where the lines on the policy debate are being drawn.

Topic headings:

  • The Senate Contenders
  • Comparing Provisions
  • Pharma's Position
  • Table: Drug Importation Bills in Congress
  • Chart: Pharmaceutical Expenditures as Percent of Total health Expenditure (Canada v.s US)

Read this article now. It's FREE...

Download PDF file

Issue: Vol. 3, No. 8: September 2004
Word Count: 900

Find other articles in related Topic Areas:

Vol 3, #8 Contents

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.